| 1:13-cv-02046 | In Re: Bendamustine Consolidated Cases | Dec 19, 2013 |
| 1:14-cv-01042 | Cephalon Inc. v. Eagle Pharmaceuticals Inc. | Aug 12, 2014 |
| 1:14-cv-01045 | Cephalon Inc. v. Eurohealth International Sarl et al | Aug 13, 2014 |
| 1:14-cv-01116 | Cephalon, Inc. v. Sagent Pharmaceuticals Inc. et al | Sep 2, 2014 |
| 1:14-cv-01117 | Cephalon, Inc. v. Nang Kuang Pharmaceutical Co LTD et al | Sep 2, 2014 |
| 1:14-cv-05180 | Cephalon, Inc. v. Nang Kuang Pharmaceutical Co., LTD et al | Sep 3, 2014 |
| 1:14-cv-01237 | Cephalon Inc. v. Agila Specialties Inc. et al. | Sep 25, 2014 |
| 1:14-cv-01238 | Cephalon Inc. v. InnoPharma Inc. | Sep 25, 2014 |
| 1:14-cv-01239 | Cephalon Inc. v. Sandoz Inc. | Sep 25, 2014 |
| 1:14-cv-01241 | Cephalon Inc. v. Dr. Reddy's Laboratories Ltd., et al. | Sep 26, 2014 |
| 1:14-cv-01242 | Cephalon Inc. v. Hospira Inc. | Sep 26, 2014 |
| 1:14-cv-01243 | Cephalon Inc. v. Sun Pharma Global FZE ., et al. | Sep 26, 2014 |
| 1:14-cv-01332 | Cephalon Inc. v. Wockhardt Bio Ltd. et al | Oct 21, 2014 |
| 1:15-cv-00179 | Cephalon Inc. v. Dr Reddy's Laboratories Ltd et al | Feb 23, 2015 |
| 1:15-cv-00404 | In Re Bendamustine Consolidated Cases II | May 19, 2015 |
| 1:15-cv-00735 | Cephalon Inc. v. Panacea Biotec, Ltd. | Aug 25, 2015 |
| IPR2016-00026 | AGILA SPECIALTIES INC. v. Cephalon, Inc. | Oct 9, 2015 |
| IPR2016-00098 | Fresenius Kabi USA, LLC v. Cephalon, Inc. | Oct 28, 2015 |
| 1:17-cv-00462 | Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al | Apr 21, 2017 |
| 1:17-cv-00483 | Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al | Apr 28, 2017 |
| 1:17-cv-00560 | Bayer Intellectual Property GmbH et al v. Micro Labs Ltd. et al | May 12, 2017 |
| 1:17-cv-00584 | Bayer Intellectual Property GmbH et al v. Mylan Pharmaceuticals Inc. | May 19, 2017 |
| 1:17-cv-00648 | Bayer Intellectual Property GmbH et al v. Sigmapharm Laboratories, LLC | May 26, 2017 |
| 1:17-cv-00648 | Southgate v. Facebook, Inc. et al | Jun 8, 2017 |
| IPR2018-01143 | Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GmbH | May 24, 2018 |
| 1:17-cv-00675 | Bayer Intellectual Property GmbH et al v. Alembic Pharmaceuticals Limited et al | Jun 2, 2017 |
| 1:17-cv-00812 | Bayer Intellectual Property GMBH et al v. InvaGen Pharmaceuticals, Inc. | Jun 23, 2017 |
| 1:17-cv-01047 | Bayer Intellectual Property GmbH et al v. Lupin Limited et al | Jul 31, 2017 |
| 1:17-cv-01129 | Bayer Intellectual Property GmbH et al v. Breckenridge Pharmaceutical, Inc. | Aug 11, 2017 |
| 1:17-cv-01154 | Cephalon, Inc. et al v. Slayback Pharma Limited Liability Company et al | Aug 16, 2017 |
| 1:17-cv-01164 | Teva Pharmaceuticals International GmbH et al v. Apotex Inc. et al | Aug 18, 2017 |
| 1:17-cv-01201 | Teva Pharmaceuticals International GmbH et al v. Fresenius Kabi USA, LLC | Aug 24, 2017 |
| 1:17-cv-01790 | Teva Pharmaceuticals International GmbH et al v. Mylan Laboratories Limited | Dec 12, 2017 |
| 1:18-cv-00117 | Teva Pharmaceuticals International GmbH et al v. Slayback Pharma Limited Liability Company | Jan 19, 2018 |
| 1:18-cv-01074 | Eagle Pharmaceuticals, Inc. et al v. Hospira, Inc. | Jul 19, 2018 |
| 1:18-cv-01459 | Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC | Sep 20, 2018 |
| 1:18-cv-01926 | Bayer Intellectual Property GMBH et al v. Teva Pharmaceuticals USA, Inc. et al | Dec 5, 2018 |
| 1:18-cv-01953 | Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC | Dec 11, 2018 |
| 1:19-cv-00880 | Bayer Intellectual Property GMBH et al v. Macleods Pharmaceuticals Ltd. et al | May 10, 2019 |
| 1:19-cv-01238 | Bayer Intellectual Property GMBH et al v. Accord Healthcare, Inc. et al | Jun 28, 2019 |
| 1:19-cv-01251 | Teva Pharmaceuticals International GmbH et al v. Lupin, Ltd. et al | Jul 2, 2019 |
| 1:19-cv-01448 | Bayer Intellectual Property GMBH et al v. Sunshine Lake Pharma Co., Ltd. et al | Aug 1, 2019 |
| 1:19-cv-01251 | TAIHO PHARMACEUTICAL CO., LTD et al v. ACCORD HEALTHCARE INC. et al | Dec 23, 2019 |
| 2:20-cv-05439 | BAYER INTELLECTUAL PROPERTY GMBH et al v. UNICHEM INC. et al | May 1, 2020 |
| 1:20-cv-00632 | Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al | May 11, 2020 |
| 1:20-cv-00962 | Cephalon, Inc. v. Aurobindo Pharma, Ltd. et al | Jul 17, 2020 |
| 2:20-cv-10378 | BAYER INTELLECTUAL PROPERTY GMBH et al v. DR. REDDY'S LABORATORIES, LTD. et al | Aug 12, 2020 |
| 1:21-cv-00695 | Teva Pharmaceuticals International GmbH et al v. Dr. Reddy's Laboratories Ltd. et al | May 13, 2021 |
| 1:21-cv-00952 | Teva Pharmaceuticals International GmbH et al v. Accord Healthcare Inc. | Jun 29, 2021 |
| 1:21-cv-01619 | Eagle Pharmaceuticals, Inc. et al v. Hospira, Inc. | Nov 16, 2021 |
| 2:22-cv-02089 | BAYER INTELLECTUAL PROPERTY GMBH et al v. CHANGZHOU PHARMACEUTICAL FACTORY | Apr 11, 2022 |
| 1:22-cv-00704 | Eagle Pharmaceuticals, Inc. v. Accord Healthcare Inc. et al | May 27, 2022 |
| 3:22-cv-05485 | BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED | Sep 9, 2022 |
| 2:22-cv-05485 | BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED | Sep 9, 2022 |
| 2:22-cv-05599 | BAYER INTELLECTUAL PROPERTY GMBH et al v. MANKIND PHARMA LIMITED | Sep 16, 2022 |
| 1:22-cv-01481 | Bayer Intellectual Property GMBH et al v. Epic Pharma, LLC | Nov 10, 2022 |
| 1:22-cv-01492 | Bayer Intellectual Property GMBH et al v. USV Private Limited | Nov 14, 2022 |
| 1:23-cv-00327 | Bayer Intellectual Property GmbH et al v. Apotex Inc. et al | Mar 24, 2023 |
| 1:23-cv-00335 | Bayer Intellectual Property GMBH et al v. ScieGen Pharmaceuticals, Inc. | Mar 24, 2023 |
| 1:23-cv-00334 | Bayer Intellectual Property GmbH et al v. Biocon Pharma Limited et al | Mar 24, 2023 |
| 1:23-cv-00490 | Teva Pharmaceuticals International GmbH et al v. BendaRx Corp. | May 4, 2023 |
| 2:23-cv-03020 | BAYER INTELLECTUAL PROPERTY GMBH et al v. AUSON PHARMACEUTICALS INC. et al | Jun 1, 2023 |
| 1:23-cv-00690 | Bayer Intellectual Property GmbH et al v. Indoco Remedies Limited et al | Jun 23, 2023 |
| 1:23-cv-01456 | Bayer Intellectual Property GMBH et al v. Umedica Laboratories Pvt. Ltd. | Dec 21, 2023 |
| 1:24-cv-00395 | Maximus, Inc. v. Holdren | Mar 12, 2024 |
